Review
Open access
Aug 2026
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research.
This review discusses endogenous CLU expression, alternative splicing, and the resulting functions of its different isoforms, providing a comprehensive guide to future mechanistic studies, biomarker development, and CLU-based drug discovery across multiple brain and eye disorders.
B. Zaman, Avinash Soundararajan, P. Pattabiraman et al.
· Pharmacology and Therapeutic... · 0 citations